Form 8-K - Current report:
SEC Accession No. 0001493152-24-003057
Filing Date
2024-01-19
Accepted
2024-01-19 16:05:39
Documents
12
Period of Report
2024-01-16
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37535
  Complete submission text file 0001493152-24-003057.txt   212207

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE age-20240116.xsd EX-101.SCH 3009
3 XBRL LABEL FILE age-20240116_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE age-20240116_pre.xml EX-101.PRE 22356
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3425
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24545603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)